🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Light Therapy in Treatment of Chronic Cluster Headache

RecruitingNAAges 18 Years - anyAllAssistance Publique Hopitaux De Marseille
NCT06540651 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Cluster headache is a primary headache. The chronic form of the disease is often difficult to treat. It is now considered a chronobiological disease. This chronobiological character is based on clinical, biological and radiological arguments. This study focuses on the use of light therapy in cluster headache. Light therapy has already been used in the treatment of other chronobiological diseases, such as seasonal depression, but also recently in the therapy of other primary headaches (such as migraine). Its aim is to re-adjust chronobiological rhythms, and it therefore seems worth testing in the chronic form of cluster headache. Light therapy is delivered to the patient using a consumer electronics device.The main objective is to evaluate the prophylactic efficacy of light therapy in patients with chronic cluster headache.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male or female, of 18 years years old or more; * Diagnosis of chronic cluster headache according to ICHD-3 criteria; * Number of seizures during baseline equal to at least 24; * Stability of prophylactic treatment for at least 1 month and commitment not to change it for the duration of the study; * Patient affiliated to the French social security system. * Patient who understands and speaks French correctly; * Patient who has given free and informed written consent. Exclusion Criteria: * Contraindication to the use of light therapy: use of a photosensitizing treatment; * Ophthalmological history: cataract, macular degeneration, glaucoma, retinitis pigmentosa; * Patients who work at night; * Other neurological, psychiatric or developmental pathologies considered incompatible with the study; * Background treatment of cluster headache with melatonin; * Persons protected by articles L1121-5, L1121-6 and L1121-8 of the French Public Health Code (pregnant or breast-feeding women, persons deprived of their liberty by judicial decision, socially vulnerable persons, adults incapable or unable to express their consent).
💊

What it tests

  • use of Luminettes ® with active light emission
  • use of Luminettes ® with a light emission presumed to have no therapeutic effect
📍

Where

2 sites
Hopital La Timone
Marseille, France
Hôpital de Cimiez
Nice, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy